Rapid Micro Biosystems Inc. (RPID) is making strides in the life sciences technology sector with its automation solutions for microbial quality control. With strong preliminary fourth-quarter and full-year 2025 results, expanding system placements, and steady recurring revenue growth, Rapid Micro Biosystems stands out as a stock on the move in the healthcare technology space.
The Lexington, Massachusetts-based company specializes in mission-critical automation solutions for microbial quality control (MQC), with its flagship Growth Direct system modernizing and automating workflows for pharmaceutical manufacturers worldwide.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.